ABVX Stock Analysis: Buy, Sell, or Hold?
ABVX - Abivax SA American Depositary Shares
$136.94
2.03 (1.50%)
β²
5d:
-1.15%
30d:
+41.83%
90d:
+8.86%
BUY
MODERATE Confidence
Analysis Updated: Jul 15, 2026 12:00 AM ET
Earnings: Sep 21, 2026
Get Alerted When ABVX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
π‘ BUY OPPORTUNITY: ABVX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
π‘ BUY OPPORTUNITY: ABVX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ABVX is currently trading at $136.94, which is considered extended relative to its 30-day fair value range of $95.08 to $135.45.
Technical Outlook: Technically, ABVX is in a strong uptrend. Immediate support is located at $131.86, while resistance sits at $147.98.
Market Sentiment: ABVX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $161.00 (+19.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ABVX is in a strong uptrend. Immediate support is located at $131.86, while resistance sits at $147.98.
Market Sentiment: ABVX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $161.00 (+19.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$95.08 -
$135.45
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($161.00)
Trading Range Analysis
30-Day Trading Range
$95.08 -
$135.45
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$131.86
Resistance Level
$147.98
Current Trend
Strong Uptrend
Technical data as of
Jul 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-41.33
Wall Street Target
$161.00
(+19.3%)
Revenue Growth (YoY)
35.2%
Share & Embed Analysis
Last updated: July 15, 2026 4:04 PM ET
Data refreshes hourly during market hours. Next update: 5:04 PM
Data refreshes hourly during market hours. Next update: 5:04 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABVX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 57 HOLD |
|
REGN
Regeneron Pharmaceutical⦠|
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 58 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 54 HOLD |
|
APLS
Apellis Pharmaceuticals β¦ |
BUY
22 analysts |
$41 | 59 HOLD |